Trial in Adult Participants With Spinocerebellar Ataxia (SCA)

Clinical trial NCT02960893 · COMPLETED

Trial details

NCT number: NCT02960893
Sponsor: Biohaven Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Spinocerebellar Ataxias Spinocerebellar Ataxia Genotype Type 1 Spinocerebellar Ataxia Genotype Type 2 Spinocerebellar Ataxia Genotype Type 3 Spinocerebellar Ataxia Genotype Type 6 Spinocerebellar Ataxia Genotype Type 7 Spinocerebellar Ataxia Genotype Type 8 Spinocerebellar Ataxia Genotype Type 10

Start date: 2016-12-15
Primary completion: 2017-08-18
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.